Skip to main content
. 2025 Aug 12;16:1629473. doi: 10.3389/fimmu.2025.1629473

Figure 7.

Box plots compare ELISA IgG levels (BAU/mL) across different groups: Healthy Control, Multiple Myeloma, non-MM hematological, and Solid. Data is shown for both females and males, with different doses (2, 3, 4) at 1 month (top) and 6 months (bottom). Statistical significance is highlighted with p-values and asterisks.

Anti-SARS-CoV-2 spike IgG levels post vaccination in serum samples from cancer and healthy cohorts within different sex groups. Comparison of serum anti-spike IgG levels in healthy, multiple myeloma, non-MM hematological cancer and solid cancer cohorts within different sex groups 1-month (A) and 6-months (B) post-vaccination. Anti-spike IgG levels were presented as Geometric Mean (GM) with 95% confidence intervals (95% CI). Box plots show median (horizontal bar), the first and third quartiles. Differences assessed by non-parametric Wilcoxon rank sum test. *p<0.05, **p<0.01.